It was suggested miR-148b and -152 that are modifying methylation status of tumor suppressor genes such as BNIP3 and SPARC can be applied in killing the pancreatic cancer cells and decreasing the tumorigenicity of these cells [57]. The gene discussed is SPARC; the disease is pancreatic neoplasm.